美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=ATROPINE"
符合检索条件的记录共39
4 页 当前第 2 页  首页 上一页 下一页 最后一页 返回检索页
11药品名称MEPERIDINE AND ATROPINE SULFATE
申请号085121产品号001
活性成分ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格0.4MG/ML;50MG/ML
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构WYETH AYERST LABORATORIES
12药品名称MEPERIDINE AND ATROPINE SULFATE
申请号085121产品号002
活性成分ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格0.4MG/ML;75MG/ML
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构WYETH AYERST LABORATORIES
13药品名称MEPERIDINE AND ATROPINE SULFATE
申请号085121产品号003
活性成分ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格0.4MG/ML;100MG/ML
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构WYETH AYERST LABORATORIES
14药品名称DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
申请号085372产品号001
活性成分ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET;ORAL规格0.025MG;2.5MG
治疗等效代码AA参比药物
批准日期Approved Prior to Jan 1, 1982申请机构LANNETT CO INC
15药品名称DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
申请号085506产品号001
活性成分ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET;ORAL规格0.025MG;2.5MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构SUN PHARMACEUTICAL INDUSTRIES INC
16药品名称DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
申请号085509产品号001
活性成分ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET;ORAL规格0.025MG;2.5MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构INWOOD LABORATORIES INC SUB FOREST LABORATORIES INC
17药品名称DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
申请号085659产品号001
活性成分ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET;ORAL规格0.025MG;2.5MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构KV PHARMACEUTICAL CO
18药品名称DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
申请号085762产品号001
活性成分ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET;ORAL规格0.025MG;2.5MG
治疗等效代码AA参比药物
批准日期Approved Prior to Jan 1, 1982申请机构MYLAN PHARMACEUTICALS INC
19药品名称DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
申请号085766产品号001
活性成分ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET;ORAL规格0.025MG;2.5MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构PRIVATE FORMULATIONS INC
20药品名称DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
申请号085876产品号001
活性成分ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET;ORAL规格0.025MG;2.5MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构WATSON LABORATORIES INC